Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment dominated by compliance issues and enforcement concerns, savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand the law and its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How and by whom will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options and sign off on advertising and promotional communications. Each of these efforts—and much more—is designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations and site management organizations
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Construction Law
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- Dietary Supplement Litigation
- Digital Health
- Diversity, Equity & Inclusion Counseling
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Industry Research and Clinical Trials
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Experience
Our Team
Media
Events
Upcoming Events
- June 17 and 21, 2024
Past Events
- May 8-10, 2024
Insights
Insights
- Firm Announcements
Epstein Becker Green Honored for Exceptional Performance in Key Practice Areas by Chambers USA 2024
5 minute read - BlogsVideo: EEO-1 Filing After June 4: What to Do Now, and How to Prepare for Next Year - Employment Law This Week2 minute read
- BlogsUnpacking Averages: Growth of AI/ML in Medicine as Evidenced by Clinical Trials12 minute read
- PublicationsFrom the Field—Bringing Value to Health Care2 minute read
- Media CoveragePaul DeCamp Quoted in “As State Minimum Wages Rise, Fewer Workers at Fed. Floor”3 minute read
- Media CoverageMelissa Jampol Quoted in “Spine Device Maker Settles FCA Case for $12M; Self-Disclosures ‘Are a Calculated Risk’” ...6 minute read
- Media CoverageDean Singewald Quoted in “EEOC Crackdown May Hint at Pay Data Requirement Reboot”3 minute read
- PublicationsConnecticut Greatly Expands Paid Sick Leave Law6 minute read
- PublicationsMajor Updates to Substance Use Disorder Treatment Confidentiality Requirements Increase Alignment with HIPAA but Raise ...2 minute read
- BlogsNuts or Not Nuts? Second Circuit Declines to Consider Whether KIND’s Use of All-Natural Is Deceptive, Misleading ...5 minute read
- Media CoverageLaw360 Names the Twelve Epstein Becker Green Attorneys Who Moved Up the Ranks in Q1 20242 minute read
- BlogsVideo: Non-Disparagement Settlements in New Jersey, DOL's AI Guidelines, OSHA Regions Shift - Employment Law This Week2 minute read
- Media CoverageGeorge Breen Quoted in “Custom Drug Makers Stay on DOJ Radar in Fla. Fraud Case”2 minute read
- BlogsPodcast: Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake – Diagnosing Health Care2 minute read
- Media CoverageErik Weibust Quoted in “Noncompete Rule Challenge Gets More Backing”3 minute read
- PublicationsCorporate Practice of Medicine: A 50 State Survey2 minute read
- BlogsVideo: DOL’s Expanded Overtime Salary Limits, EEOC’s Sexual Harassment Guidance, NY’s Mandatory Paid Prenatal ...2 minute read
- Blogs
Litigating Nutrition: Class Action Battles Over Dietary Supplements – Speaking of Litigation Video Podcast
41 minute read - Media CoverageHoward Wall Featured in “Legal Notes”2 minute read
- Media CoverageLaw360’s Hottest Firms and Stories Features Epstein Becker Green Insight on False Claims Act Enforcement Trends ...1 minute read
- Media CoverageJames Boiani Quoted in “Jazz Pharma to Fight FDA in Court Over Rival Sleep Drug Approval”5 minute read
- BlogsUnpacking Averages: Assessing the Products Included in FDA's Voluntary Malfunction Summary Reporting Program11 minute read
- PublicationsMid-2024 FCA Enforcement and Litigation Trends to Watch3 minute read
- BlogsFederal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies?7 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Fighting the Bots Is the New Attorney Niche”4 minute read
- PublicationsThe IRA: Reducing Inflation or Threatening Patient Access?2 minute read
- PublicationsState Supreme Courts and Ballot Initiatives: Arizona, Florida Exemplify the Abortion Battle Playing Out in the States ...14 minute read
- Firm AnnouncementsSeven Epstein Becker Green Attorneys to Serve in AHLA Leadership Positions2 minute read
- Firm AnnouncementsWelcome to Nashville: Epstein Becker Green Adds Howard T. Wall III as Of Counsel4 minute read
- BlogsVideo: Avoiding Legal Illusions - Crafting Effective Arbitration Agreements - Employment Law This Week2 minute read
- Media CoverageKate Rigby, Dan Fahey Quoted in “Why the FTC’s Noncompete Rule Will Make Chicago Hospitals Look Over Their Shoulders” ...3 minute read
- PublicationsViral Layoff Videos Are Trending: Employers Should Proceed with Caution2 minute read
- BlogsHHS Extends the Antidiscrimination Provisions of the Affordable Care Act to Patient Care Decision Support Tools, Including ...16 minute read
- BlogsIt’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices ...8 minute read
- Media CoverageErik Weibust Quoted in “Battles Over Noncompete Clauses Poised to Heat Up in Statehouses”3 minute read
- PublicationsThe FTC's Noncompete Rule Is Likely Dead on Arrival2 minute read
- Media CoverageErik Weibust Quoted in “US FTC Votes Through Non-Compete Clause Ban Spelling Uncertainty for Trade Secret Strategy” ...2 minute read
- Media CoverageGenevieve Murphy-Bradacs Quoted in “EEOC Criminal History Suit Brings Fresh Focus to Old Policy”3 minute read
- Media CoveragePeter Steinmeyer Quoted in “New Ban on Noncompetes Could Have Big Impact on Health Care”4 minute read
- Media CoverageJeff Ruzal Quoted in “New Overtime Rule Raises Salary Level in Two Phases”2 minute read
- Media CoverageErik Weibust Quoted in “Takeaways from the FTC's Noncompetes Ban”2 minute read
- BlogsVideo: SCOTUS Expands Title VII, EEOC’s Final PWFA Rule, AI Screening Tools - Employment Law This Week3 minute read
- Media Coverage
Kate Heffernan Featured in AHLA’s Speaking of Health Law Podcast, “Trends Related to Research Misconduct” ...
1 minute read - Media CoveragePeter Steinmeyer Quoted in “Businesses Face ‘Seismic Shift’ After FTC Bans Noncompetes. Here’s What They Should Do ...2 minute read
- Media CoveragePeter Steinmeyer Quoted in “For Traders, the FTC Ban on Non-Competes Comes with Big Catches”2 minute read
- Firm Announcements
Fourteen Epstein Becker Green Attorneys Named to the 2024 Washington, DC, Super Lawyers and Rising Stars Lists
7 minute read - Firm AnnouncementsEpstein Becker Green’s Consistent and Enthusiastic Support of AHLA Reflected in the 2024 Top Honors List2 minute read
- Media CoveragePaul DeCamp Quoted in “Federal Rules, State Action Complicate In-House Labor Strategies”3 minute read
- Media CoverageHelaine Fingold Quoted in “Finalized Broker Pay Cap Appears to Exclude FMOs, but Impact Remains Unclear”2 minute read
- Firm Announcements
Epstein Becker Green Recognized Among Largest Health Care Law Firms by Modern Healthcare
1 minute read